Projects per year
Personal profile
Research Strategic Pillar
The Chief Research Officer, has determined that UTMB research should be prioritized into six health communities. This researcher has received the following badge(s):
Research Strategic Pillar Keywords
- Infectious/ Immunological Health
Fingerprint
Dive into the research topics where Chien-Te Tseng is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Evaluate the efficacy of VNT-101 and other compounds against highly pathogenic avian influenza (HPAI) viruses in vitro and in vivo
Tseng, C.-T. (PI)
Novo Nordisk Fonden ( Award #NNF24SA0097217)
1/1/25 → 12/31/26
Project: Research project
-
Covid-19 and elevated plasma Reelin are risk factors for Alzheimer's disease
Tseng, C.-T. (PI)
University of Texas SouthWestern Med Cen ( Award #251113)
12/1/24 → 11/30/26
Project: Research project
-
Pan-COVID Therapeutic
Tseng, C.-T. (PI)
Larix Bioscience, LLC ( Award #1R43GH0023900100)
10/1/22 → 9/29/23
Project: Research project
-
Project 1
Tseng, C.-T. (PI)
Stanford University ( Award #1U19AI17142101)
5/16/22 → 4/17/25
Project: Research project
-
Characterizing temporal and global host innate immune responses against SARS-CoV-1 and -2 infection in pathologically relevant human lung epithelial cells
Tat, V. Y., Drelich, A. K., Huang, P., Khanipov, K., Hsu, J. C., Widen, S., Tseng, C. T. K. & Golovko, G., Jan 2025, In: PloS one. 20, 1 January, e0317921.Research output: Contribution to journal › Article › peer-review
Open Access -
Dual Inhibitors of SARS-CoV-2 3CL Protease and Human Cathepsin L Containing Glutamine Isosteres Are Anti-CoV-2 Agents
Kumar, V., Zhu, J., Chenna, B. C., Hoffpauir, Z. A., Rademacher, A., Rogers, A. M., Tseng, C. T., Drelich, A., Farzandh, S., Lamb, A. L. & Meek, T. D., Jan 15 2025, In: Journal of the American Chemical Society. 147, 2, p. 1631-1648 18 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Rapid restoration of potent neutralization activity against the latest Omicron variant JN.1 via AI rational design and antibody engineering
Liao, Y., Ma, H., Wang, Z., Wang, S., He, Y., Chang, Y., Zong, H., Tang, H., Wang, L., Ke, Y., Cai, H., Li, P., Tang, J., Chen, H., Drelich, A., Peng, B., Hsu, J., Tat, V., Tseng, C. T. K. & Song, J. & 20 others, , Feb 11 2025, In: Proceedings of the National Academy of Sciences of the United States of America. 122, 6, e2406659122.Research output: Contribution to journal › Article › peer-review
Open Access -
Superior replication, pathogenicity, and immune evasion of a Texas dairy cattle H5N1 virus compared to a historical avian isolate
Octaviani, C. P., Huang, P., Bi-Hung, P., Gray, G. C. & Tseng, C. T. K., Dec 2025, In: Scientific reports. 15, 1, 8797.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations
Westberg, M., Su, Y., Zou, X., Huang, P., Rustagi, A., Garhyan, J., Patel, P. B., Fernandez, D., Wu, Y., Hao, C., Lo, C. W., Karim, M., Ning, L., Beck, A., Saenkham-Huntsinger, P., Tat, V., Drelich, A., Peng, B. H., Einav, S. & Tseng, C. T. K. & 2 others, , Mar 13 2024, In: Science Translational Medicine. 16, 738, p. eadi0979 eadi0979.Research output: Contribution to journal › Article › peer-review
8 Scopus citations